文献速递妇科产科

改良Surelift前壁-顶端经阴道网片治疗晚期泌尿生殖道脱垂:1年手术与功能结局

Anterior-Apical Transvaginal Mesh (Surelift) for Advanced Urogenital Prolapse: Surgical and Functional Outcomes at 1 Year.
PubMed 文献 · J Minim Invasive Gynecol · 2020-05-13

1年客观治愈率97.6%、主观治愈率92.8%,网片 extrusion 率4.8%,QOL及下尿路症状显著改善,但新发尿动力学压力性尿失禁18.9%、压力性尿失禁21.6%。

要点

  • 改良Surelift网片1年客观治愈率97.6%,主观治愈率92.8%。
  • 网片 extrusion 率4.8%,QOL及下尿路症状显著改善。
  • 新发尿动力学压力性尿失禁18.9%、压力性尿失禁21.6%,但无需手术。

核心结论

  • 改良Surelift网片术后1年客观与主观治愈率良好,网片 extrusion 率4.8%。
  • 下尿路症状及生活质量显著改善,新发压力性尿失禁增加但不足以需手术。

研究设计与样本

  • 所有患者行改良Surelift经阴道网片骨盆重建手术。
  • 术前及术后6至12个月完成72小时排尿日记、尿动力学检查及多个经验证的生活质量问卷。

主要发现

  • 1年客观治愈率97.6%,主观治愈率92.8%。
  • 生活质量评分术后显著改善。
  • 新发尿动力学压力性尿失禁18.9%,压力性尿失禁21.6%。
  • 网片 extrusion 率4.8%。

关键数值与推荐

  • 客观治愈定义为前壁和顶端脱垂POP-Q分期≤I期。
  • 主观治愈基于盆腔器官脱垂困扰量表6(POPDI-6)阴性回答。

临床怎么用

  • 改良Surelift可用于症状性前壁或顶端POP≥III期的重建手术,需告知患者新发压力性尿失禁风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To determine the objective and subjective outcomes of pelvic organ prolapse (POP) surgery using a modified Surelift system (Neomedic International, Barcelona, Spain) and to evaluate surgical complications and postoperative impact on quality of life (QOL) and lower urinary tract symptoms. DESIGN: Retrospective cohort study. SETTING: Tertiary-care university hospital. PATIENTS: Patients with symptomatic anterior or apical POP stage III and above. INTERVENTIONS: All patients underwent pelvic reconstructive surgery with a modified Surelift transvaginal mesh kit. MEASUREMENTS AND MAIN RESULTS: Eighty-three women who underwent pelvic reconstructive surgery with a modified Surelift for symptomatic anterior or apical prolapse stage III and above from April 2018 to January 2019 were reviewed retrospectively. All completed a 72-hour voiding diary, urodynamic study, and multiple validated QOL questionnaires at baseline and at between 6 and 12 months postoperatively. Descriptive statistics were used for demographics and perioperative data. Paired-samples t test and the McNemar test were applied for comparison of pre- and postoperative continuous and categoric data, respectively. The primary outcomes were the objective cure of POP, defined as anterior and apical prolapse Pelvic Organ Prolapse Quantification System ≤ stage I, and subjective cure on the basis of negative answers to Pelvic Organ Prolapse Distress Inventory 6. The objective and subjective cure rates at 1 year were 97.6% and 92.8%, respectively. There were significant improvements in QOL scores postoperatively. Although bladder outlet obstruction improved, de novo urodynamic stress incontinence and stress urinary incontinence were increased at 18.9% and 21.6%, respectively, at 1-year follow-up. The mesh extrusion rate was 4.8%. CONCLUSION: A modified Surelift has good objective and subjective cure rates at 1 year postoperatively with 4.8% mesh extrusion rate. There was significant improvement in lower urinary tract symptoms and QOL. De novo urodynamic stress incontinence at 6 months to 12 months was increased, but it was not sufficiently bothersome to warrant surgery.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Lo TS, Ng KL, Huang TX, et al. Anterior-Apical Transvaginal Mesh (Surelift) for Advanced Urogenital Prolapse: Surgical and Functional Outcomes at 1 Year. J Minim Invasive Gynecol. 2020. PMID: 32416263. doi:10.1016/j.jmig.2020.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。